In glioma cell cultures, silencing of uPAR and cathepsin B downregulates the expression of CD133, Nestin, Sox2 and Bmi1 and reduces the number of glioma-initiating cells (Gopinath et al., 2013). The gene discussed is PROM1; the disease is central nervous system cancer.